Conference Programme

Tentative Conference Agenda

Explore the proposed two-day programme developed around the conference Session Tracks and aligned United Nations Sustainable Development Goals.

Conference Format Hybrid Conference In-person and virtual participation
Programme 2 Days 15–16 May 2027
Academic Scope 11 Tracks Conference Session Tracks
Research Scope 20 Areas Call for Papers themes
SDG Alignment 3 SDGs SDGs 3, 4 and 9
Tentative Agenda & Timings

Session timings, sequence, track grouping and allocations are tentative and subject to change. Final timings will be confirmed closer to the conference. All timings follow the local time of the conference location.

Day 01

Opening, Keynote & Technical Sessions

15 MAY 2027 HYBRID
  1. 09:00 AM 09:30 AM

    Registration, Welcome Kit Collection & Virtual Check-in

    Participant arrival, credential verification and virtual lobby access.

    HYBRID
  2. 09:30 AM 09:45 AM

    Networking Tea & Digital Welcome

    Informal networking for on-site and virtual participants.

    HYBRID
  3. 09:45 AM 10:30 AM

    Welcome Address, Opening Plenary & Keynote Presentation I

    Opening of the conference and introduction to its research focus.

    PLENARY
  4. 10:30 AM 12:30 PM

    Concurrent Technical Session I

    3 TRACKS
    Track 01
    Cancer Cell Biology and Tumor Microenvironment
    34
    Track Overview

    This track focuses on the intricate biology of cancer cells and their interactions within the tumor microenvironment. It aims to explore the cellular mechanisms that drive tumor progression and metastasis.

    Track 02
    Diagnostic and Prognostic Biomarkers in Oncology
    39
    Track Overview

    This session will delve into the latest advancements in the identification and validation of cancer biomarkers for diagnosis and prognosis. Emphasis will be placed on their clinical applications and implications for patient management.

    Track 03
    Innovations in Cancer Detection and Imaging Technologies
    39
    Track Overview

    This track will highlight cutting-edge technologies in cancer detection and imaging, including novel imaging modalities and techniques. Discussions will center on their potential to enhance early diagnosis and treatment outcomes.

  5. 12:30 PM 01:30 PM

    Lunch & Networking Break

    Refreshment interval and networking opportunity.

    BREAK
  6. 01:30 PM 03:30 PM

    Concurrent Technical Session II

    3 TRACKS
    Track 04
    Molecular Mechanisms of Tumor Suppressor Genes
    34
    Track Overview

    This session will examine the role of tumor suppressor genes in cancer development and progression. Researchers will present findings on the molecular pathways and mechanisms that govern their function.

    Track 05
    Signal Transduction Pathways in Cancer: Focus on Protein Kinases
    39
    Track Overview

    This track will investigate the role of protein kinases in cancer-related signal transduction pathways. It will cover their potential as therapeutic targets and the implications for cancer treatment.

    Track 06
    Role of Steroids and Their Receptors in Cancer Biology
    34
    Track Overview

    This session will explore the impact of steroids and their receptors on cancer biology and therapy. Discussions will include the mechanisms of action and therapeutic implications of steroid signaling in various cancers.

  7. 03:30 PM 04:00 PM

    Interactive Q&A, Day 1 Summary & Group Photo

    Closing interaction and key takeaways from the first day.

    CLOSING
Day 02

Keynote, Technical Sessions & Awards

16 MAY 2027 HYBRID
  1. 09:00 AM 09:15 AM

    Participant Check-in & Day 2 Welcome

    On-site attendance confirmation and virtual lobby access.

    HYBRID
  2. 09:15 AM 10:00 AM

    Keynote Presentation II

    Expert address on the future of the conference research domain.

    PLENARY
  3. 10:00 AM 12:00 PM

    Concurrent Technical Session III

    3 TRACKS
    Track 07
    Transgenic Models in Cancer Research
    34
    Track Overview

    This track will focus on the use of transgenic mouse models to study cancer biology and therapeutic responses. Researchers will share insights into how these models contribute to our understanding of cancer mechanisms.

    Track 08
    Apoptosis Regulation in Cancer Therapy
    34
    Track Overview

    This session will address the role of apoptosis in cancer and its regulation as a therapeutic strategy. Presentations will cover novel approaches to modulate apoptotic pathways in cancer treatment.

    Track 09
    RNA Interference and Its Applications in Cancer Treatment
    34
    Track Overview

    This track will explore the potential of RNA interference as a therapeutic approach in cancer biology. Discussions will focus on the challenges and successes of implementing RNAi in clinical settings.

  4. 12:00 PM 01:00 PM

    Lunch & Networking Break

    Refreshment interval and professional networking.

    BREAK
  5. 01:00 PM 03:00 PM

    Concurrent Technical Session IV

    2 TRACKS
    Track 10
    Carcinogenesis and Mutagenesis: Mechanisms and Implications
    34
    Track Overview

    This session will investigate the mechanisms of carcinogenesis and mutagenesis, highlighting the genetic and environmental factors involved. It aims to provide insights into prevention strategies and therapeutic interventions.

    Track 11
    Advancements in Cancer Therapeutics and Drug Development
    39
    Track Overview

    This track will showcase novel approaches to cancer therapeutics, including drug discovery and development processes. Emphasis will be placed on innovative strategies that enhance treatment efficacy and reduce resistance.

  6. 03:00 PM 03:30 PM

    Publications, Best Paper & Best Presentation Awards

    Publication guidance and recognition of outstanding research contributions.

    AWARDS
  7. 03:30 PM 04:00 PM

    Valedictory Session, Closing Remarks & Group Photo

    Conference summary, acknowledgements and formal conclusion.

    CLOSING
Aligned SDGs
3 Good Health and Well-being 4 Quality Education 9 Industry, Innovation and Infrastructure

Be Part of ICCSCT-27

Submit your research or complete your conference registration.